• Rapid Acting Antidepressants (Hardback) 9780128201893
1 1
£148.78 GBP
£190.00 GBP £148.78 GBP
Sale Sold out
Free UK Shipping

Freshly Printed - allow 10 days lead

Rapid Acting Antidepressants

Provides the authority and expertise of leading contributors who discuss advances in pharmacology

Ronald S. Duman (Volume editor), John H. Krystal (Volume editor)

9780128201893, Elsevier Science

Hardback, published 26 June 2020

402 pages
22.9 x 15.1 x 2.7 cm, 0.77 kg

The Advances in Pharmacology series presents a variety of chapters from the best authors in the field.

Part I – Neurobiology of ketamine effects

    1. Effects of ketamine and other rapidly acting antidepressants on hippocampal excitatory and inhibitory transmission

      2. Allie J. Widman and Lori L. McMahon

    2. Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition

      3. Bernhard Luscher, Mengyang Feng and Sarah J. Jefferson

    3. The role of eEF2 kinase in the rapid antidepressant actions of ketamine

      4. Kanzo Suzuki and Lisa M. Monteggia

      Part II – The rapid therapeutic effects of ketamine

    4. Clinical overview of NMDA-R antagonists and clinical practice

      5. Pasha A. Davoudian and Samuel T. Wilkinson

    5. Ketamine for depression clinical issues

      6. Syed Z. Iqbal and Sanjay J. Mathew

    6. Chronic stress pathology and ketamine-induced alterations in functional connectivity in major depressive disorder: An abridged review of the clinical evidence

      7. Lynnette A. Averill, Samar Fouda, James W. Murrough and Chadi G. Abdallah

    7. Neurobiological biomarkers of response to ketamine

      8. Bashkim Kadriu, Elizabeth D. Ballard, Ioline D. Henter, Stephen Murata, Nimesha Gerlus and Carlos A. Zarate Jr

    8. Relapse prevention in treatment resistant major depressive disorder with rapid-acting antidepressants

      9. Jaskaran B. Singh, Maggie Fedgchin, Ella J. Daly and Wayne C. Drevets

    9. The emergence of ketamine as a novel treatment for posttraumatic stress disorder

      10. Adriana Feder, Sarah B. Rutter, Daniela Schille and Dennis S. Charney

      Part III – Novel rapid-acting antidepressant mechanisms related to ketamine

    10. mGlu2/3 receptor as a novel target for rapid acting antidepressants

      11. Shigeyuki Chaki

    11. Involvement of muscarinic receptor mechanisms in antidepressant drug action

      12. Jeffrey M. Witkin, Jodi L. Smith, Lalit K. Golani, Emily A. Brooks and Anna E. Martin

    12. The antidepressant efficacy of the muscarinic antagonist scopolamine: Past findings and future directions

Wayne C. Drevets, Anindya Bhattacharya and Maura L. Furey

Subject Areas: Pharmacology [MMG]
View full details